Advisory Research’s Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share AUS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-229,700
Closed -$388K 422
2021
Q3
$388K Buy
229,700
+119,925
+109% +$178K 0.02% 276
2021
Q2
$190K Buy
+109,775
New +$159K 0.01% 325

Other funds holding AUS.WS

Advisory Research's AUS.WS Position: Q4 2021 in Review

Advisory Research sold out of Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (AUS.WS) in Q4 2021, closing a stake of 229,700 shares — an estimated $388K sold.

Advisory Research first reported a position in AUS.WS in Q2 2021 and held it in 2 quarters. The position peaked at $388K in Q3 2021. 67 funds tracked by Wall St. Rank hold AUS.WS as of Q4 2021.

  • Advisory Research reported no remaining Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • Advisory Research sold 229,700 Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2021, an estimated $388K.
  • Advisory Research first reported a position in Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
  • Advisory Research's Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $388K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2021.

Based on Advisory Research's 13F filing for Q4 2021, filed 11 Feb 2022.